Pura Vida Investments LLC decreased its holdings in shares of LivaNova PLC (NASDAQ:LIVN) by 45.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 40,000 shares of the company’s stock after selling 32,971 shares during the quarter. LivaNova makes up approximately 2.3% of Pura Vida Investments LLC’s portfolio, making the stock its 16th biggest position. Pura Vida Investments LLC’s holdings in LivaNova were worth $3,659,000 as of its most recent SEC filing.
A number of other hedge funds have also bought and sold shares of the stock. Nelson Van Denburg & Campbell Wealth Management Group LLC lifted its stake in LivaNova by 4.7% during the fourth quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 4,159 shares of the company’s stock worth $380,000 after purchasing an additional 186 shares during the last quarter. Bank of Montreal Can lifted its stake in LivaNova by 6.7% during the fourth quarter. Bank of Montreal Can now owns 4,744 shares of the company’s stock worth $434,000 after purchasing an additional 297 shares during the last quarter. Retirement Systems of Alabama lifted its stake in LivaNova by 0.5% during the fourth quarter. Retirement Systems of Alabama now owns 63,073 shares of the company’s stock worth $5,769,000 after purchasing an additional 326 shares during the last quarter. State of Tennessee Treasury Department lifted its stake in LivaNova by 2.0% during the fourth quarter. State of Tennessee Treasury Department now owns 20,406 shares of the company’s stock worth $1,867,000 after purchasing an additional 406 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in LivaNova by 5.7% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 8,073 shares of the company’s stock worth $738,000 after purchasing an additional 435 shares during the last quarter. Hedge funds and other institutional investors own 89.50% of the company’s stock.
Several research firms recently weighed in on LIVN. BidaskClub upgraded LivaNova from a “hold” rating to a “buy” rating in a research note on Wednesday, February 20th. Needham & Company LLC reaffirmed a “buy” rating and set a $120.00 price target (down previously from $135.00) on shares of LivaNova in a research report on Wednesday, February 27th. ValuEngine lowered LivaNova from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, November 28th. BTIG Research reaffirmed a “hold” rating on shares of LivaNova in a research report on Tuesday, March 5th. Finally, Zacks Investment Research raised LivaNova from a “strong sell” rating to a “hold” rating in a research report on Wednesday, January 2nd. Four research analysts have rated the stock with a hold rating and four have given a buy rating to the company. LivaNova currently has a consensus rating of “Buy” and a consensus price target of $128.75.
LIVN opened at $95.84 on Friday. The company has a market cap of $4.67 billion, a price-to-earnings ratio of 30.23, a PEG ratio of 2.75 and a beta of 0.87. LivaNova PLC has a 52 week low of $79.96 and a 52 week high of $131.54. The company has a current ratio of 1.07, a quick ratio of 0.76 and a debt-to-equity ratio of 0.09.
LivaNova (NASDAQ:LIVN) last released its quarterly earnings results on Wednesday, February 27th. The company reported $1.12 EPS for the quarter, topping the consensus estimate of $1.10 by $0.02. The company had revenue of $297.00 million for the quarter, compared to analyst estimates of $294.98 million. LivaNova had a positive return on equity of 9.64% and a negative net margin of 17.11%. The firm’s revenue was up 6.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.88 earnings per share. Equities analysts predict that LivaNova PLC will post 3.33 earnings per share for the current fiscal year.
In other LivaNova news, insider Alistair Simpson sold 450 shares of LivaNova stock in a transaction that occurred on Thursday, January 10th. The stock was sold at an average price of $90.10, for a total transaction of $40,545.00. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Daniel Jeffrey Moore sold 1,500 shares of LivaNova stock in a transaction that occurred on Friday, February 15th. The stock was sold at an average price of $100.44, for a total value of $150,660.00. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 4,950 shares of company stock worth $465,585. 0.41% of the stock is currently owned by corporate insiders.
ILLEGAL ACTIVITY WARNING: “LivaNova PLC (LIVN) Position Trimmed by Pura Vida Investments LLC” was originally published by Transcript Daily and is owned by of Transcript Daily. If you are accessing this piece of content on another publication, it was stolen and republished in violation of US and international copyright and trademark laws. The correct version of this piece of content can be read at https://transcriptdaily.com/2019/03/17/livanova-plc-livn-position-trimmed-by-pura-vida-investments-llc.html.
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates in two segments, Cardiac Surgery and Neuromodulation. The Cardiac Surgery segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, perfusion tubing systems, cannulae and accessories for extracorporeal circulation, and systems for autotransfusion and autologous blood washing, as well as surgical tissue and mechanical heart valve replacements, and repair products for damaged or diseased heart valves.
Further Reading: What are the risks of holding treasury bonds?
Want to see what other hedge funds are holding LIVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LivaNova PLC (NASDAQ:LIVN).
Receive News & Ratings for LivaNova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova and related companies with MarketBeat.com's FREE daily email newsletter.